dsm-firmenich Enhances Shareholder Value with Buyback Program
dsm-firmenich is making notable strides in its commitment to enhance shareholder value through its ongoing share repurchase program. The company, a leader in nutrition, health, and beauty, initiated the program with a remarkable plan to repurchase ordinary shares valued at €1 billion. This strategic action is part of a broader objective to support its capital structure and fulfill obligations under its share-based compensation plans.
Strategic Buyback Initiative Begins
The program commenced on April 1, representing an initial investment commitment of €580 million. Within this amount, €80 million is specifically allocated to fulfilling commitments related to the Group’s share-based compensation, while the remaining €500 million aims to effectively reduce the issued capital.
Recent Developments in Repurchase Activity
In late June, significant news emerged as dsm-firmenich announced an increase in the total allocation of its share repurchase program to €1,080 million. This increase followed the successful sale of its stake in the Feed Enzymes Alliance, providing the company with additional resources to return capital to shareholders.
Recent Share Repurchase Performance
In the timeframe between July 21 to July 25, dsm-firmenich reported repurchasing a total of 392,392 shares at an average price of €88.5 per share. This activity amounted to a total consideration of about €34.7 million. As of now, the total number of shares repurchased under this program stands at 5,287,440 shares, reflecting an average repurchase price of €93.09, leading to a total investment of approximately €492.2 million.
Looking Ahead: Completion Timeline
The share repurchase program is scheduled for completion no later than January 30, 2026. This timeline demonstrates dsm-firmenich’s commitment to maintaining a robust capital strategy while pursuing initiatives aimed at improving shareholder value.
About dsm-firmenich
dsm-firmenich is recognized as a pioneering force in the sectors of nutrition, health, and beauty. The company is dedicated to innovating and producing essential nutrients, flavors, and fragrances necessary for contributing to the well-being of the world’s growing population. With a rich portfolio that utilizes natural and renewable ingredients backed by science and technology, dsm-firmenich strives to provide sustainable solutions that are desirable for consumers and beneficial for the planet.
Headquartered in both Kaiseraugst, Switzerland, and Maastricht, Netherlands, dsm-firmenich operates in nearly 60 countries, generating revenues exceeding €12 billion. The planet is supported by a dedicated workforce of around 30,000 employees who contribute daily to the progress of life and well-being across the globe.
Frequently Asked Questions
1. What is the purpose of dsm-firmenich's share repurchase program?
The primary purpose is to enhance shareholder value, repurchase shares, and support commitments to share-based compensation plans.
2. How much has dsm-firmenich committed to the repurchase program?
dsm-firmenich initially committed €1 billion, with an increase to €1,080 million following strategic business developments.
3. When will the share repurchase program be completed?
The program is expected to conclude by January 30, 2026, demonstrating the company’s commitment to its capital strategy.
4. How many shares have been repurchased as of now?
To date, dsm-firmenich has repurchased a total of 5,287,440 shares within the ongoing program.
5. What is the average price of shares repurchased by the company?
The average repurchase price of the shares is €93.09, signifying the company's strategic pricing activities.
